基于临床实践的传统和个性化剂量策略的临床实践比较,用于治疗性埃诺克萨帕林
Anthony Damiani1, Viviane De Menezes Caceres2, Greg Roberts3
1SA Pharmacy, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.
Pharmacology research & perspectives
|January 24, 2025
概括
传统的埃诺沙巴林剂量经常导致超出范围的抗Xa因子水平,特别是在肥胖或功能障碍患者中. 个性化剂量可能会降低高水平,但可能会增加亚治疗水平,需要进一步研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 血栓形成研究研究
背景情况:
- 治疗性埃诺沙巴林剂量旨在达到最佳的抗Xa因子水平.
- 传统的剂量策略可能无法考虑个体患者的因素,如功能和体重.
- 抗Xa因子水平的变化可能会影响疗效和安全性.
研究的目的:
- 为了比较传统和个性化治疗性埃诺沙巴林剂量策略之间的抗Xa因子水平.
- 在住院患者中识别与范围之外的抗Xa因子水平相关的因素.
- 评估剂量策略对临床结果的影响.
主要方法:
- 这是一项多中心,追溯的队列研究,涉及278名接受治疗性西巴林治疗的住院患者.
- 患者被分为常规 (n=141) 和个性化 (n=137) 剂量组.
- 抗Xa因子水平在剂后3-5小时测量,至少在开始后48小时测量.
主要成果:
- 在两组中,超出范围的抗Xa因子水平是常见的 (35-40%).
- 传统的剂量与个性化剂量相比,与高于范围的水平 (OR 2.50) 的更高概率有关.
- 个体化剂量显示,低于范围水平的几率更高 (OR 2.27).
- 在传统组中,功能下降和BMI增加与范围以上水平有关.
- 在个性化剂量时没有观察到这种关联.
结论:
- 传统的治疗用埃诺沙巴林剂量增加了肥胖或功能障碍患者抗Xa因子水平高于范围的风险.
- 个性化的埃诺沙巴林剂量可能会减轻高水平,但会带来次治疗水平的风险.
- 需要进行进一步的研究,以优化因子沙巴林治疗的个性化剂量策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
603
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
603
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.8K
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
One-Compartment Open Model for IV Bolus Administration: General Considerations
154
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
154


